| [1] |
Sung H，Ferlay J，Siegel RL，et al. Global Cancer Statistics 2020：GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries［J］. CA Cancer J Clin，2021，71（3）：209-249.
|
| [2] |
Bernas M，Thiadens SRJ，Stewart P，et al. Secondary lymphedema from cancer therapy［J］. Clin Exp Metastasis，2022，39（1）：239-247.
|
| [3] |
Salinas-Huertas S，Luzardo-González A，Vázquez-Gallego S，et al. Risk factors for lymphedema after breast surgery：A prospective cohort study in the era of sentinel lymph node biopsy［J］. Breast Dis，2022，41（1）：97-108.
|
| [4] |
Akezaki Y，Tominaga R，Kikuuchi M. Risk Factors for Lymphedema in Breast Cancer Survivors Following Axillary Lymph Node Dissection［J］. Prog Rehabili Med，2019，4：20190021.
|
| [5] |
Brahma B，Yamamoto T. Breast cancer treatment-related lymphedema（BCRL）：An overview of the literature and updates in microsurgery reconstructions［J］. Eur J Surg Oncol，2019，45（7）：1138-1145.
|
| [6] |
He L，Qu H，Wu Q，et al. Lymphedema in survivors of breast cancer［J］. Oncol Lett，2020，19（3）：2085-2096.
|
| [7] |
Donker M，van Tienhoven G，Straver ME，et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer（EORTC 10981-22023 AMAROS）：a randomised，multicentre，open-label，phase 3 non-inferiority trial［J］. Lancet Oncol，2014，15（12）：1303-1310.
|
| [8] |
Gowda AU，Nie J，Mets E，et al. Risk Factors for Lymphedema After Breast Conservation Therapy and Oncoplastic Reduction［J］. Ann Plast Surg，2021，87（3）：248-252.
|
| [9] |
Rockson SG. The Role of Body Mass Index in Breast Cancer-Associated Lymphedema［J］. Lymphat Res Biol，2020，18（6）：501.
|
| [10] |
Ana Carolina Padula Ribeiro Pereira，Koifman RJ，Bergmann A. Incidence and risk factors of lymphedema after breast cancer treatment：10 years of follow-up［J］. Breast，2017，36：67-73.
|
| [11] |
Gillespie TC，Sayegh HE，Brunelle CL，et al. Breast cancer-related lymphedema：risk factors，precautionary measures，and treatments［J］. Gland Surg，2018，7（4）：379-403.
|
| [12] |
Zhu W，Li D，Li X，et al. Association between adjuvant docetaxel-based chemotherapy and breast cancer-related lymphedema［J］. Anticancer Drugs，2017，28（3）：350-355.
|
| [13] |
Swaroop MN，Ferguson CM，Horick NK，et al. Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema：results from a large prospective cohort［J］. Breast Cancer Res Treat，2015，151（2）：393-403.
|
| [14] |
Kim M，Park IH，Lee KS，et al. Breast Cancer-Related Lymphedema after Neoadjuvant Chemotherapy［J］. Cancer Res Ttreat，2015，47（3）：416-423.
|
| [15] |
Committee E. The Diagnosis and Treatment of Peripheral Lymphedema：2016 Consensus Document of the International Society of Lymphology［J］. Lymphology，2016，49（4）：170-184.
|
| [16] |
Brunelle CL，Taghian AG. ASO Author Reflections：Breast Cancer-Related Lymphedema—A Suggested Clinical Pathway for Diagnosis［J］. Ann Surg Oncol，2022，29（2）：1003-1004.
|
| [17] |
Byun HK，Chang JS，Im SH，et al. Risk of Lymphedema Following Contemporary Treatment for Breast Cancer：An Analysis of 7617 Consecutive Patients From a Multidisciplinary Perspective［J］. Ann Surg，2021，274（1）：170-178.
|
| [18] |
Forte AJ，Huayllani MT，Boczar D，et al. Use of bioimpedance spectroscopy for prospective surveillance and early diagnosis of breast cancer-related lymphedema［J］. Breast Dis，2021，40（2）：85-93.
|
| [19] |
Erdinc Gunduz N，Dilek B，Sahin E，et al. Diagnostic Contribution of Ultrasonography in Breast Cancer-Related Lymphedema［J］. Lymphat Res Biol，2021，19（6）：517-523.
|
| [20] |
Kim G，Donohoe K，Smith MP，et al. Use of non-contrast MR in diagnosing secondary lymphedema of the upper extremities［J］. Clin Imaging，2021，80：400-405.
|
| [21] |
Yamamoto T，Yamamoto N，Ishiura R. Indocyanine Green Lymphography for Lymphedema Screening following Breast Cancer Treatment［J］. Plast Reconstr Surg，2017，139（6）：1365e-1366e.
|
| [22] |
Akita S，Unno N，Maegawa J，et al. A phase Ⅲ，multicenter，single-arm study to assess the utility of indocyanine green fluorescent lymphography in the treatment of secondary lymphedema［J］. J Vasc Surg Venous Lymphat Disord，2022，10（3）：728-737.e3.
|
| [23] |
Gentili F，Mazzei FG，Monteleone I，et al. Comparison of indocyanine green fluorescence lymphangiography and magnetic resonance lymphangiography to investigate lymphedema of the extremities［J］. Ann Ital Chir，2021，92：452-459.
|
| [24] |
Nelson NL. Breast Cancer-Related Lymphedema and Resistance Exercise：A Systematic Review［J］. J Strength Cond Res，2016，30（9）：2656-2665.
|
| [25] |
Chang DW，Dayan J，Greene AK，et al. Surgical Treatment of Lymphedema：A Systematic Review and Meta-Analysis of Controlled Trials. Results of a Consensus Conference［J］. Plast Reconstr Surg，2021，147（4）：975-993.
|
| [26] |
Chen K，Sinelnikov MY，Shchedrina MA，et al. Surgical Management of Postmastectomy Lymphedema and Review of the Literature［J］. Ann Plast Surg，2021，86（3S Suppl 2）：S173-S176.
|
| [27] |
Chollet C，Malloizel-Delaunay J，Cabarrou B，et al. Liposuction-assisted brachioplasty in breast cancer-related lymphedema：Impact on volume reduction and quality of life［J］. J Plast Reonstr Aesthet Surg，2021，74（7）：1633-1701.
|
| [28] |
Karlsson T，Karlsson M，Ohlin K，et al. Liposuction of Breast Cancer-Related Arm Lymphedema Reduces Fat and Muscle Hypertrophy［J］. Lymphat Res Biol，2022，20（1）：53-63.
|
| [29] |
Campisi C，Bellini C，Campisi C，et al. Microsurgery for lymphedema：clinical research and long-term results［J］. Microsurgery，2010，30（4）：256-260.
|
| [30] |
Chang DW，Suami H，Skoracki R. Reply：a prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema［J］. Plast Reconstr Surg，2014，133（6）：888e-889e.
|
| [31] |
Chen WF，Yamamoto T，Fisher M，et al. The "Octopus" Lymphaticovenular Anastomosis：Evolving Beyond the Standard Supermicrosurgical Technique［J］. J Reconstr Microsurg，2015，31（6）：450-457.
|
| [32] |
Mihara M，Hara H，Furniss D，et al. Lymphaticovenular anastomosis to prevent cellulitis associated with lymphoedema［J］. Br J Surg，2014，101（11）：1391-1396.
|
| [33] |
Qiu SS，Pruimboom T，Cornelissen AJM，et al. Outcomes following lymphaticovenous anastomosis（LVA）for 100 cases of lymphedema：results over 24-months follow-up［J］. Breast Cancer Res Treat，2020，184（1）：173-183.
|
| [34] |
Wolfs JAGN，de Joode LGEH，van der Hulst RRWJ，et al. Correlation between patency and clinical improvement after lymphaticovenous anastomosis（LVA）in breast cancer-related lymphedema：12-month follow-up［J］. Breast Cancer Res Treat，2020，179（1）：131-138.
|
| [35] |
Chan JCY，Taranto GD，Elia R，et al. Postoperative care after lymphaticovenous anastomosis［J］. Arch Plast Surg，2021，48（3）：333-335.
|
| [36] |
Becker C，Assouad J，Riquet M，et al. Postmastectomy lymphedema：long-term results following microsurgical lymph node transplantation［J］. Ann Surg，2006，243（3）：313-315.
|
| [37] |
Moon KC，Kim HK，Lee TY，et al. Vascularized lymph node transfer for surgical treatments of upper versus lower extremity lymphedema［J］. J Vasc Surg Venous Lymphat Disord，2022，10（1）：170-178.
|
| [38] |
Buettner M，Bode U. Lymph Node Transplantation and Its Immunological Significance in Animal Models［J］. Clin Dev Immnol，2011，2011：353510.
|
| [39] |
Basta MN，Gao LL，Wu LC. Operative treatment of peripheral lymphedema：a systematic meta-analysis of the efficacy and safety of lymphovenous microsurgery and tissue transplantation［J］. Plast Reconstr Surg，2014，133（4）：905-913.
|
| [40] |
向泓雨，刘荫华. 制定高质量临床实践指南推动中国乳腺外科诊治规范化进程［J］，中华普外科手术学杂志（电子版），2022，16（2）：119-123.
|
| [41] |
张毅，万安第. 开展中国乳腺外科腔镜手术多中心研究的思考［J］，中华普外科手术学杂志（电子版），2022，16（2）：127-132.
|